<code id='C12D228206'></code><style id='C12D228206'></style>
    • <acronym id='C12D228206'></acronym>
      <center id='C12D228206'><center id='C12D228206'><tfoot id='C12D228206'></tfoot></center><abbr id='C12D228206'><dir id='C12D228206'><tfoot id='C12D228206'></tfoot><noframes id='C12D228206'>

    • <optgroup id='C12D228206'><strike id='C12D228206'><sup id='C12D228206'></sup></strike><code id='C12D228206'></code></optgroup>
        1. <b id='C12D228206'><label id='C12D228206'><select id='C12D228206'><dt id='C12D228206'><span id='C12D228206'></span></dt></select></label></b><u id='C12D228206'></u>
          <i id='C12D228206'><strike id='C12D228206'><tt id='C12D228206'><pre id='C12D228206'></pre></tt></strike></i>

          focus

          focus

          author:fashion    Page View:6259

          Which presentations are worth catching at ASCO this weekend? What is exon-skipping? And how do you pronounce bronchiectasis?

          This week on “The Readout LOUD,” we preview some of the research that will be presented at the American Society of Clinical Oncology conference in Chicago. We also discuss the latest news in the health and life sciences, including a milestone in lung disease R&D and a Duchenne muscular dystrophy confirmatory trial failure.  

          advertisement

          To read more about Merus’ combination therapy, go here; For more on Johnson & Johnson’s mixed data, click here; For more on Nippon Shinyaku’s Duchenne drug trial failure, go here; To read more on Insmed’s bronchiectasis treatment, click here; To sign up for STAT’s ASCO newsletter, click here.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          leisure time

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Medicare Advantage enrollment grows 7.1% to 33.4 million people
          Medicare Advantage enrollment grows 7.1% to 33.4 million people

          PabloMartinezMonsivais/APRoughly33.4millionadultsolderthan65andpeoplewithdisabilitieswereenrolledina

          read more
          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more

          Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

          DarronCummings/APEliLillysaidTuesdaythatitwillpurchaseDICETherapeutics,asmallcompanydevelopinganexpe